Cite

HARVARD Citation

    Yu, H. et al. (2022). A Randomized First‐in‐Human Study With UB‐312, a UBITh® α‐Synuclein Peptide Vaccine. Movement disorders. 37 (7), pp. 1416-1424. [Online]. 
  
Back to record